European Commission Approves mAbxience’s Bevacizumab For The Treatment Of Certain Types Of Cancer
mAbxience, a global fully-fledged biotech company, with over a decade of experience in the development, manufacture and commercialization of
Read moremAbxience, a global fully-fledged biotech company, with over a decade of experience in the development, manufacture and commercialization of
Read moreNew York, New York–(Newsfile Corp. – April 1, 2021) – Enerkon Solar International (OTC Pink: ENKS) names new Board and
Read moreCanada NewsWire After recently launching its Advanced Analytical Testing services, CBDV successfully receives orders through their new online payment platform
Read moreCanada NewsWire TORONTO , April 5, 2021 /CNW/ – On Tuesday, March 30, 2021 , Anthony Durkacz , a
Read moreCanada NewsWire OXFORD, Ohio and COCONUT CREEK, Fla. , March 23, 2021 /CNW/ – PsyBio Therapeutics Corp. (TSXV: PSYB)
Read moreDrug compound’s target therapeutic area include solid cancers and COVID-19 Canada NewsWire SINGAPORE , March 22, 2021 /CNW/ — Xylonix,
Read moreToronto, Ontario–(Newsfile Corp. – March 22, 2021) – FACT, Inc. (OTC Pink: FCTI) (the “Company” or “FACT“) a global leader
Read moreHarvest Health & Recreation Inc. To Hold Fourth Quarter and Full Year 2020 Earnings Conference Call on March 30,
Read moreCanada NewsWire The Company expects to have ibogaine manufactured and in use for research by Q4. VANCOUVER, BC , March
Read moreBentonville, Arkansas–(Newsfile Corp. – March 1, 2021) – GLUCODOWN® (OTC Pink: GLUC) revenues at Amazon for the month of February 2021
Read more